LEADER 00970nam0-22003131i-450- 001 990006504330403321 005 20100201190329.0 035 $a000650433 035 $aFED01000650433 035 $a(Aleph)000650433FED01 035 $a000650433 100 $a20010426d1984----km-y0itay50------ba 101 0 $aita 102 $aIT 105 $ay-------001yy 200 1 $a<>via del consenso$edal protocollo Spadolini del 28 giugno 1981 all'accordo Scotti del 22 gennaio 1983$fMassimo Mascini, Maurizio Ricci 210 $aRoma$cCEDIS$d1984 215 $a123 p.$d21 cm 225 1 $aOrganizzazione aziendale e relazioni industriali$v6 676 $a331.8 700 1$aMascini,$bMassimo$f<1943- >$0140115 701 1$aRicci,$bMaurizio$f<1946- >$0319048 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990006504330403321 952 $aCOLLEZ. 1460 (6)$b28189$fFSPBC 959 $aFSPBC 996 $aVia del consenso$9654504 997 $aUNINA LEADER 05004nam 22006015 450 001 9910494558003321 005 20251113202602.0 010 $a981-336-850-0 024 7 $a10.1007/978-981-33-6850-7 035 $a(CKB)4100000011994644 035 $a(MiAaPQ)EBC6688960 035 $a(Au-PeEL)EBL6688960 035 $a(PPN)260306436 035 $a(OCoLC)1262554045 035 $a(DE-He213)978-981-33-6850-7 035 $a(EXLCZ)994100000011994644 100 $a20210730d2021 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aMedicinal Plants for Lung Diseases $eA Pharmacological and Immunological Perspective /$fedited by Kamal Dua, Srinivas Nammi, Dennis Chang, Dinesh Kumar Chellappan, Gaurav Gupta, Trudi Collet 205 $a1st ed. 2021. 210 1$aSingapore :$cSpringer Nature Singapore :$cImprint: Springer,$d2021. 215 $a1 online resource (625 pages) 225 1 $aBiomedical and Life Sciences Series 311 08$a981-336-849-7 320 $aIncludes bibliographical references. 327 $aChapter 1. Immunopathology of respiratory diseases -- Chapter 2. Introduction to Chronic Respiratory Diseases: A Pressing Need for Novel Therapeutic Approaches -- Chapter 3. Role of Indian Herbal Medicine in the treatment of Pulmonary Diseases -- Chapter 4. Asthma-induced inflammatory responses and reversal by botanicals -- Chapter 5. Medicinal plants in targeting asthma -- Chapter 6. Incipient need of medicinal plants in targeting chronic obstructive pulmonary disease -- Chapter 7. Utilization of Natural Compounds for Treatment of Tuberculosis-I -- Chapter 8. Medicinal plants in the treatment of Tuberculosis-II -- Chapter 9. Medicinal Plants in the Treatment of tuberculosis-III -- Chapter 10.Natural compounds as versatile potential therapeutic agents of lung cancer -- Chapter 11. Exploring the potential of medicinal plants in Lung Cancer -- Chapter 12. Effect of Medicinal Plants against Lung Cancer -- Chapter 13. Medicinal Plants used in the treatment of pulmonary hypertension- I -- Chapter 14.Medicinal Plants used in the treatment of pulmonary hypertension-II -- Chapter 15. Herbal bioactives for the treatment of idiopathic pulmonary fibrosis -- Chapter 16. Medicinal Plants targeting Bronchitis -- Chapter 17. Role of medicinal plants in the treatment of pulmonary edema -- Chapter 18. Medicinal Plants Used in the Treatment of Influenza a Virus Infections -- Chapter 19. Medicinal Plants used in the treatment of influenza A virus infections -- Chapter 20. COVID-19 pandemic panic: prophylactic as well as therapeutic management with traditional ethnic phytopharmaceuticals with challenging nano-spray inhaler and advanced drug delivery system -- Chapter 21. Targeting SARS-CoV2 novel corona (COVID-19) virus infection using medicinal plants -- Chapter 22. Promising plant based bioactive natural products in combating SARS-CoV2 novel corona (COVID-19) virus infection -- Chapter 23. Medicinal plant based advanced drug delivery system for the treatment of chronic lung diseases -- Chapter 24. Medicinal Plant Based Advanced Drug Delivery System for the Treatment of Chronic Lung Diseases -- Chapter 25. Application of nanodrugs derived from active metabolites of medicinal plants for the treatment of inflammatory and lung diseases: Recent advances. 330 $aThis book summarizes experimentally-supported research on the therapeutic efficacy of plant extracts and their constituents on a range of respiratory diseases including infections. It discusses the pharmacological, cellular and molecular factors involved in the pathogenies of respiratory diseases and their modulation by plant-derived compounds. Additionally, it underlines the growing relevance of medicinal plant-based advanced drug delivery systems for treating lung diseases providing maximal therapeutic efficacy with better patient compliance. Overall, this comprehensive book is a blend of translational, biological, chemical and drug delivery aspects of medicinal plants employed in targeting respiratory diseases and attracts a range of audiences including physiochemist, translational and clinical researchers working in the field of respiratory diseases. 410 0$aBiomedical and Life Sciences Series 606 $aHuman physiology 606 $aPharmaceutical chemistry 606 $aDrug delivery systems 606 $aHuman Physiology 606 $aPharmaceutics 606 $aDrug Delivery 615 0$aHuman physiology. 615 0$aPharmaceutical chemistry. 615 0$aDrug delivery systems. 615 14$aHuman Physiology. 615 24$aPharmaceutics. 615 24$aDrug Delivery. 676 $a616.248 702 $aDua$b Kamal 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910494558003321 996 $aMedicinal plants for lung diseases$92834348 997 $aUNINA